Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05072262 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

DSAEK/DMEK and Cystoid Macular Edema - the Role for Topical NSAIDs (Nepafenac) (DMEC)

Name: DSAEK/DMEK and Cystoid Macular Edema - the Role for Topical NSAIDs (Nepafenac) (DMEC) — clinical trial record (NCT05072262)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: DMEC

StatusRecruiting

PhasePhase 4

SponsorOslo University Hospital

Started2022-11-25

View on ClinicalTrials.gov ↗

Record status

This record was last updated December 1, 2022 (before its estimated June 2024 completion). Its status may not reflect the trial's current state.

Amendment history

2022-11-26

Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2

Trial statusNot Yet Recruiting→Recruiting

Start dateestimated 2022-05→confirmed 2022-11-25

Study sites0→1

2022-03-27

Study Status v1

Primary completion date2023-06→2024-06

Completion date2025-10→2026-10

Start date2021-10→2022-05

2021-10-05

Original filing

Oslo University Hospital

220 trials monitored

See 3 trials at risk

The DMEC trial is a randomized clinical two-arm trial comparing inflammation and cystoid macular edema for the medication regimens postoperative topical NSAIDs and steroids to only postoperative topical steroids in patients undergoing corneal endothelial transplantations (DSAEK or DMEK).

Trial Details

NCT Number	NCT05072262
Lead Sponsor	Oslo University Hospital
Conditions	Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Descemet Membrane Endothelial Keratoplasty (DMEK)
Enrollment	300 participants
Start Date	2022-11-25
Primary Completion	2024-06 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2022-12-01